申请人:THE JOHNS HOPKINS UNIVERSITY
公开号:US10695322B2
公开(公告)日:2020-06-30
New antimicrobials targeting L,D-transpeptidases, non-classical cysteine peptidases, have been developed and their unique chemical structures identified. Carbapenems and penems of the present invention are unique among β-lactams as they acylate and inhibit L,D-transpeptidases, which likely results in their superior antimicrobial potency. These new antimicrobial agents can be used alone, or in combination with other classic antimicrobial agents that target D,D transpeptidases, when treating bacterial infections.
针对非典型半胱氨酸肽酶 L,D-反肽酶的新型抗菌剂已经开发出来,并确定了其独特的化学结构。本发明的碳青霉烯类和青霉烯类在β-内酰胺类药物中是独一无二的,因为它们能酰化并抑制 L,D-转肽酶,这可能是它们具有卓越抗菌效力的原因。在治疗细菌感染时,这些新型抗菌剂可单独使用,也可与其他针对 D,D-转肽酶的经典抗菌剂联合使用。